Atrys Health SA
F:A2T
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Atrys Health SA
F:A2T
|
ES |
|
D
|
Daou Data Corp
KOSDAQ:032190
|
KR |
|
D
|
Denison Mines Corp
XMUN:IUQ
|
CA |
|
F
|
FirstEnergy Corp
DUS:FE7
|
US |
|
E
|
Eaton Corporation PLC
F:3EC
|
IE |
|
C
|
Carpenter Technology Corp
F:XTY
|
US |
|
P
|
Pakuwon Jati Tbk PT
IDX:PWON
|
ID |
|
C
|
Carpenter Technology Corp
SWB:XTY
|
US |
|
Aryzta AG
SIX:ARYN
|
CH |
|
Allegro Microsystems Inc
NASDAQ:ALGM
|
US |
|
A
|
Airbus SE
F:AIR
|
NL |
|
Henry Boot PLC
LSE:BOOT
|
UK |
|
I
|
Investec PLC
XMUN:IVKA
|
UK |
|
A
|
Astro Resources NL
ASX:ARO
|
AU |
Wall St Price Targets
A2T Price Targets Summary
Atrys Health SA
According to Wall Street analysts, the average 1-year price target for A2T is 6.29 EUR with a low forecast of 5.16 EUR and a high forecast of 7.37 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A2T's stock price target?
Price Target
6.29
EUR
According to Wall Street analysts, the average 1-year price target for A2T is 6.29 EUR with a low forecast of 5.16 EUR and a high forecast of 7.37 EUR.
What is the Revenue forecast for Atrys Health SA?
Projected CAGR
13%
Over the last 9 years, the compound annual growth rate for Revenue has been 46%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Atrys Health SA?
Projected CAGR
30%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 34%. The projected CAGR for the next 3 years is 30%.
